Skyclarys™ – first drug approved for Friedreich’s ataxia

Biogen’s omaveloxolone (Skyclarys™) is the first approved medical treatment for Friedreich’s ataxia. It is approved for adults and adolescents (16 years and older) and corrects mitochondrial dysfunction, reduces oxidative stress and may therefore slow the progression of the rare inherited neurodegenerative disease.